Improving the standard of care for people living with liver disease

Hepatic Health represents a new educational resource from Gilead Sciences and is designed to meet the educational needs of healthcare professionals and people with an interest in the field of liver disease; particularly with regard to chronic hepatitis C virus (HCV) infection and hepatitis B virus (HBV) infection.

Hepatic Health is a reflection of Gilead’s ongoing commitment to advancing the care of people with liver disease.

Simplification and Test and Treat Strategies Towards Hepatitis C Elimination

The investigator-sponsored research program ‘Simplification and Test and Treat Strategies Towards Hepatitis C Elimination’ (STAT) aims to support research projects focused on ways to overcome barriers in hepatitis C (HCV) care.

The importance of clinical context in hepatitis B screening

In an exclusive interview for Hepatic Health, Dr Patrick Kennedy, consultant hepatologist, discusses the importance of clinical context when diagnosing hepatitis B (HBV). In the article and video, Dr Kennedy explains the need for further investigation when presented with abnormal liver function test (LFTs) results, and why clinical context can mean normal LFT results warrant more exploration.

Find out more

Improving the standard of care for people living with liver disease

Gilead’s investigator-sponsored research program: STAT

Simplification and Test and Treat Strategies Towards Hepatitis C Elimination

Expert insight with Dr Patrick Kennedy

The importance of clinical context in hepatitis B screening

Looking for in-depth information on liver disease?

HCV

Hepatitis C

Background on the global and local burden of HCV; the expanding role of primary care in HCV management; diagnosis and pre-treatment assessment; HCV treatment and ongoing care. The important role of hepatitis nurses in the HCV care pathway is also discussed.

HBV

Hepatitis B

A comprehensive summary of currently available knowledge on HBV is provided here – information focuses on screening, diagnosis and management of people living with HBV.

N&N

NAFLD & NASH

The aim of this section is to summarise the most recent data on NAFLD and NASH including the burden, staging, diagnosis and management approaches such as lifestyle interventions and multidisciplinary management.

An educational resource designed to meet the needs of healthcare professionals and people with an interest in liver disease

Learn more about us

Providing relevant information across the care continuum

Hepatic Health can assist healthcare professionals of many specialties, including:

Primary care providers
Diabetologists
Hepatologists
Hepatitis nurses
Endocrinologists
Addiction specialists

All aspects of screening, evaluation and treatment of HCV, HBV, NAFLD and NASH with progressive fibrosis are addressed, including expert insights on complex issues and scientific updates from annual meetings.

Gilead R&D has helped advance the treatment of chronic hepatitis C infection and help manage chronic hepatitis B infection. Today, the company’s liver disease research focuses on advancing the care of patients living with liver diseases through its research and development efforts.

Learn more

Specialist interests

Discover liver disease content related to specific areas of interest, including diabetes, obesity, endocrinology, addiction and harm reduction and primary care.

Find out more